Asia Strengthens Health Screenings as West Bengal Confirms Nipah Virus Cases

Asia tightens health checks as West Bengal confirms Nipah cases

With airport health screenings reinstated across parts of Asia, India‘s Union health authorities on January 27, 2026 said the Nipah situation in West Bengal remains contained. Officials reported two laboratory-confirmed infections and emphasized that intensified surveillance and testing have not identified any additional patients.

In a detailed update, the ministry stated: “A total of 196 contacts linked to the confirmed cases have been identified, traced, monitored, and tested. All traced contacts have been found asymptomatic and have tested negative for Nipah Virus Disease.” It added: “No additional Nipah Virus Disease cases have been detected so far,” and that “the situation is under constant monitoring, and all necessary public health measures are in place.”

Special pathogens expert Lauren Sauer underscored the surveillance challenge posed by a return of the virus to eastern India, noting: “This represents a return of Nipah to this area after a long gap, which is concerning from a surveillance standpoint.”

What is driving precautionary steps beyond India

Border and airport controls have expanded in recent days, reflecting epidemiological characteristics of Nipah: a zoonotic virus with a historically high case fatality ratio and documented person-to-person spread in close-contact settings. While public-health agencies stress that community risk outside affected areas remains low, transport hubs are moving quickly to boost screening and information for travelers, drawing on systems set up during the COVID-19 pandemic.

• Thailand: “Thailand’s Department of Disease Control screens travellers from West Bengal, India at Suvarnabhumi & Don Mueang airports starting 25 January amid Nipah virus outbreak. Health officials implement strict measures as passengers show excellent cooperation at checkpoints,” the Thai government said, adding that temperature checks, health declaration forms, and “health beware” cards are now standard for arrivals from affected areas.
• Nepal: Health desks and symptom screening have been set up at Kathmandu’s international airport and at key land borders with India, where officials say the goal is early detection and swift referral rather than blanket travel bans.
• Taiwan: Health authorities have announced plans to list Nipah as a Category 5 notifiable disease, triggering mandatory reporting and special control measures if adopted after a public comment period, and aligning airport monitoring with the country’s broader infectious-disease control law.

Current outbreak snapshot (as of January 27, 2026)

Clinical and transmission profile in brief

• Reservoir and spillover: Fruit bats (Pteropus genus) are the natural hosts; spillover to humans occurs via contaminated food, direct animal contact (notably pigs in past outbreaks), or close contact with an infected person.
• Human-to-human transmission: Documented in household and healthcare settings during several South Asian outbreaks, especially where infection-prevention controls are weak or delayed.
• Symptoms spectrum:
  • Early: fever, headache, myalgia, cough, sore throat, difficulty breathing
  • Severe: encephalitis with drowsiness, confusion, seizures; rapid deterioration to coma in some cases
• Case fatality ratio: typically 40-75% across outbreaks, varying with clinical care capacity and timeliness.
• Diagnostics: RT-PCR on clinical specimens and serology (ELISA) are used during acute and convalescent phases.
• Medical countermeasures: No licensed vaccines or antivirals; clinical care is supportive, often resource intensive, and depends heavily on ICU-level monitoring and respiratory support.

For foundational reference on disease characteristics, see the WHO Nipah virus fact sheet and the CDC’s concise overview.

How India’s response is structured

National and state teams have deployed standard outbreak-control playbooks that combine case finding, laboratory confirmation, and infection-prevention protocols for healthcare facilities. Officials noted that authorities “initiated prompt and comprehensive public health measures in accordance with established protocols.” They reported that investigators subsequently conducted “enhanced surveillance, laboratory testing, and field investigations,” which “ensured timely containment of the cases.”

Those protocols sit within India’s legal framework for epidemic management, notably the Epidemic Diseases Act and the National Disaster Management architecture, giving state governments powers to mandate isolation, direct private facilities, and control movement if required.

Regional policy measures at a glance

Endemicity, seasonality, and system readiness

Indian experts describe Kerala and West Bengal as areas where sporadic Nipah events have recurred over time, overlapping with cross-border transmission zones that include Bangladesh. As one senior clinician put it: “Nipah virus is a zoonotic disease… These sporadic outbreaks have occurred in both Kerala and West Bengal. But even Bangladesh is endemic for the Nipah virus… The current outbreak was first reported among 5 health workers in West Bengal after a person died of an unknown disease, and later on, these 5 health professionals were involved. An ongoing investigation is now underway into another 100 to 200 people who have been exposed… Nipah virus is that it is highly infectious and fatal… The person either gets symptoms of encephalitis or severe respiratory disease, and mortality is 40 to 75%, which is very high,” said Arora.

• Seasonal signal: South Asian outbreaks have often clustered between December and April, aligning with environmental and behavioral factors that bring people into contact with bat-contaminated foods.
• Healthcare implications: Even small clusters can place pressure on isolation capacity, staff protection, and laboratory throughput because standard care for severe encephalitis and respiratory failure is resource intensive.
• Countermeasure pipeline: Research programs continue to evaluate candidate vaccines and monoclonal antibodies; access remains limited at present. As one official highlighted, “There is a very limited supply of these monoclonal antibodies globally, and India has taken this up as a very important initiative to ensure they are available within the country.”

Key risk factors and population-level implications

• Occupational and exposure risks:
  • Close contact with infected pigs or bats, or with their secretions
  • Consumption of foods contaminated by bats (for example, raw date palm sap)
  • Unprotected close-contact care of an infected person in household or clinical settings
• System stressors:
  • Surge capacity for isolation, ICU-level supportive care, and trained staff
  • Supply chains for diagnostics, PPE, and candidate therapeutics for investigational use
  • Cross-border coordination to harmonize screening, reporting, and data sharing, particularly along high-traffic land corridors.
• Equity considerations:
  • Rural and peri-urban communities near bat habitats may face higher environmental exposure
  • Frontline healthcare workers and informal caregivers bear disproportionate risk without robust infection-prevention controls

Timeline highlights

• 2007: Last confirmed Nipah outbreak in West Bengal before the current event, with subsequent years seeing activity primarily in Kerala and Bangladesh.
• January 25-27, 2026: Asian airports begin reinstituting fever checks and traveler advisories tied to flights from West Bengal; India’s Health Ministry confirms two cases and reports 196 contacts tested.

The bottom line for public institutions

Public-health agencies in India and neighboring jurisdictions are acting within established protocols for a high-consequence zoonotic virus: identify cases quickly, test and isolate in equipped facilities, protect healthcare workers, and communicate transparently. With no approved vaccines or antivirals, rapid surveillance and strong clinical care remain the core containment tools while research continues. For governments, the West Bengal cases are also a live test of post-COVID border health systems, data-sharing agreements, and the ability to scale targeted measures without resorting to broad, economically disruptive travel restrictions.